Sustained Impact of Real-time Continuous Glucose Monitoring in Adults With Type 1 Diabetes on Insulin Pump Therapy: Results After the 24-Month RESCUE Study.

Objective: In recent years, a growing number of people with type 1 diabetes gained access to real-time continuous glucose monitoring (rtCGM). Long-term benefits of rtCGM are unclear because of a lack of large studies of long duration. We evaluated whether real-world rtCGM use up to 24 months offered benefits, particularly in those living with impaired awareness of hypoglycemia (IAH).

One-year metabolic outcomes in patients with type 2 diabetes treated with exenatide in routine practice.

Aim: The study objective was to analyze, in everyday practice, the long-term metabolic effects of exenatide (for 9 and 12 months) in patients with type 2 diabetes not responding to treatments with metformin and sulphonylurea at maximum dosages.

Methods: A total of 299 type 2 diabetics were recruited from 14 centres specializing in diabetes care across Belgium. Main study endpoints were changes in HbA(1c), weight and waist circumference, and tolerability and compliance.

[Thyrotoxic periodic paralysis].

Thyrotoxic Periodic Paralysis associates the clinical picture of hyperthyroidism with bouts of paralysis due to hypokalaemia. The hypokalaemia is due to a massive shift of potassium from the extra- to the intracellular compartment. This entity is found almost exclusively in Asian males.